FDA approvals: what each drug is officially indicated for Sources: FDA prescribing information for Wegovy (2025), Mounjaro (2026), Zepbound (2025)
The study's main objective is to measure how much the pills can reduce blood sugar levels in people with Type 2 diabetes, but it will also gauge weight loss
For the other claims, the applicant provided only background evidence, specifically retrospective studies, which describe findings for a predicate device, the Axoguard Nerve Protector TM , which received FDA 510(k) clearance on January 10, 2014, not the nominated device, the Axoguard HA+ Nerve Protector TM
More about this Pin Related interests Skin Care Tips 0:05 Weve solved a problem thats been around since the first person said skin care, and thats absorption
George will typically guide patients in setting these goals and adapting lifestyle changes such as sleep hygiene and eating habits that can further aid the weight loss journey with semaglutide
One of the biggest impact of this news is that more or more primary care physicians will start doing FIB-4 and primary screening for MASLD/MASH